experts advise drug ministry to grant conditional use permit for celltrion's covid-19 treatment
Published 3 years ago • 712 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
1:29
celltrion's covid-19 treatment gets conditional approval for medium and high-risk patients
-
0:40
celltrion's covid-19 treatment cleared for limited use in europe
-
0:39
s. korea's celltrion covid-19 antibody drug ready for use
-
2:10
gov't recommends use of antiviral drugs for covid-19 treatment
-
53:28
[full] the daily report : ministry of food and drug safety approves pfizer's vaccine for five to ...
-
3:59
is coke safe to drink? conversation with coca-cola's ceo | cna insider
-
1:11:55
what is the latest research telling us about what medications help? - connie lee
-
3:37
cordlife says automatic alert system on temperature experienced disruption
-
15:45
arirang news [full]: president moon holds new year's press conference; addresses contentious issues
-
0:35
s. korea to mass-produce antibody treatment of covid-19 this month
-
0:32
celltrion's covid-19 antibody drug under real-time review by eu regulator
-
46:16
[full] 🔊 s. korean gov't briefing on covid-19 | third wave of covid-19 and quarantine measures
-
1:41
local researchers come up with new artery-cleansing medication made by tangerines
-
24:07
coronavirus special report: medicine's critical challenge
-
51:37
[live] the daily report : u.s. drugmaker 'merck' asks for emergency use authorization for its ...
-
1:59
singapore researchers use artificial intelligence to find ideal drug cocktail to treat covid-19
-
2:42
verify: are israeli scientists working on a drug to cure covid-19?
-
53:40
[full] the daily report : s. korea authorizes pfizer's oral covid-19 treatment for emergency use
-
2:14
covid-19 treatments being developed across the globe
-
0:30
drug safety ministry revokes license of arthritis drug invossa for mislabeling cell ingredient
-
5:07
keep covid-19 ‘emergency’ status for efficiency of international coordination: expert
-
1:08:06
what clinicians need to know about therapeutic options for covid-19